Significant Ownership of Prosight Management, LP

Large-stake snapshot 1 signal
Large-stake filing summary
  • Recent SEC Schedule 13D/G filings for Prosight Management, LP focus on large-stake beneficial ownership disclosures and amendments.
  • Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
Manager Names, identifiers, and filing context for this profile. 2 identity fields
Manager signature
W. Lawrence Hawkins - Sole Manager of the General Partner
Manager location
Dallas, TX

Significant Ownership of Prosight Management, LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
STTK Shattuck Labs, Inc. Common Stock, $0.0001 par value per share 9.9% $15,638,344 6,543,240 Prosight Management, LP 30 Sep 2025
ADCT ADC THERAPEUTICS SA Common Shares 6.8% $31,366,151 +$4,743,267 8,477,338 +18% Prosight Management, LP 31 Dec 2025
JANX Janux Therapeutics, Inc. Common Stock, $0.001 par value per share 5.3% $43,569,636 3,157,220 W. Lawrence Hawkins 03 Feb 2026
VINC Vincerx Pharma, Inc. Common Stock, $0.0001 par value per share 5% $7,823 111,755 Prosight Management, LP 31 Dec 2024
MGTX MeiraGTx Holdings plc Ordinary Shares, $0.00003881 par value per share 4% $23,702,995 -$8,448,499 3,211,788 -26% W. Lawrence Hawkins 31 Dec 2025
OKUR OnKure Therapeutics, Inc. Class A Common Stock, par value $0.0001 per share 2.4% $4,464,204 +$1,064,044 978,992 +31% Prosight Management, LP 30 Jun 2026
MURA Mural Oncology plc Ordinary Shares, nominal value $0.01 per share 0% $0 -$1,862,820 0 -100% Prosight Management, LP 30 Sep 2025

Schedules 13D/G Reported by Prosight Management, LP:

Sym Target Class Ownership Change Current shares Change Value Reporting name Form Report period Filing date
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .